Iterum Therapeutics (ITRM) Short Interest Ratio & Short Volume → 😱 This phenomenon is smashing regular market gains (From MillPub) (Ad) Free ITRM Stock Alerts $1.53 -0.01 (-0.65%) (As of 04/30/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Iterum Therapeutics Short Interest DataCurrent Short Volume1,200,000 sharesPrevious Short Volume1,230,000 sharesChange Vs. Previous Month-2.44%Dollar Volume Sold Short$1.85 millionShort Interest Ratio / Days to Cover2.0Last Record DateApril 15, 2024Outstanding Shares16,555,000 sharesFloat Size16,010,000 sharesShort Percent of Float7.50%Today's Trading Volume157,708 sharesAverage Trading Volume159,293 sharesToday's Volume Vs. Average99% Short Selling Iterum Therapeutics ? Sign up to receive the latest short interest report for Iterum Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatITRM Short Interest Over TimeITRM Days to Cover Over TimeITRM Percentage of Float Shorted Over Time Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide Iterum Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,200,000 shares $1.85 million -2.4%7.5%2 $1.54 3/31/20241,230,000 shares $1.89 million +1.7%9.4%2.1 $1.54 3/15/20241,210,000 shares $1.77 million +24.1%9.3%2.1 $1.46 2/29/2024975,300 shares $1.21 million -16.6%7.5%1.7 $1.24 2/15/20241,170,000 shares $1.76 million +2,132.8%8.9%2 $1.50 1/31/202452,400 shares $80,696.00 +9.4%0.4%0.1 $1.54 Get the Latest News and Ratings for ITRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202447,900 shares $88,136.00 -70.8%0.4%0.3 $1.84 12/31/2023164,100 shares $323,277.00 -17.1%1.3%1.1 $1.97 12/15/2023198,000 shares $352,440.00 -8.2%1.5%1.4 $1.78 11/30/2023215,700 shares $405,516.00 +258.9%1.7%1.7 $1.88 11/15/202360,100 shares $52,587.50 +22.9%0.5%0.7 $0.88 10/31/202348,900 shares $31,956.15 +0.6%0.4%1.5 $0.65 10/15/202348,600 shares $36,936.00 -16.2%0.4%1.3 $0.76 9/30/202358,000 shares $46,458.00 +6.6%0.5%1.5 $0.80 9/15/202354,400 shares $43,465.60 -2.9%0.4%1.4 $0.80 8/31/202356,000 shares $49,946.40 -34.7%0.4%1.4 $0.89 8/15/202385,700 shares $83,129.00 +72.8%0.7%1.7 $0.97 7/31/202349,600 shares $51,584.00 -29.9%0.4%1 $1.04 7/15/202370,800 shares $83,544.00 +10.8%0.6%1.4 $1.18 6/30/202363,900 shares $68,373.00 -5.8%0.5%1.2 $1.07 6/15/202367,800 shares $75,936.00 +5.4%0.5%1.2 $1.12 5/31/202364,300 shares $73,945.00 -5.7%0.5%0.9 $1.15 5/15/202368,200 shares $77,195.58 -10.7%0.5%1 $1.13 4/30/202376,400 shares $89,388.00 -26.5%0.6%1.2 $1.17 4/15/2023103,900 shares $122,602.00 -0.5%0.8%1.5 $1.18 3/31/2023104,400 shares $104,389.56 -32.4%0.8%1.3 $1.00 3/15/2023154,400 shares $154,400.00 -15.5%1.2%1.5 $1.00 2/28/2023182,700 shares $208,278.00 -14.9%1.5%0.5 $1.14 2/15/2023214,700 shares $266,228.00 -31.4%1.8%0.6 $1.24 1/31/2023312,800 shares $434,792.00 -12.0%2.6%0.9 $1.39 1/15/2023355,300 shares $426,360.00 +23.3%3.0%1 $1.20 12/30/2022288,200 shares $242,088.00 +106.0%2.4%0.9 $0.84 12/15/2022139,900 shares $169,279.00 -29.7%1.2%0.4 $1.21 11/30/2022199,100 shares $258,830.00 -8.4%1.7%3.6 $1.30 11/15/2022217,400 shares $315,230.00 +85.0%1.8%3.1 $1.45 10/31/2022117,500 shares $198,575.00 -42.6%1.0%1.4 $1.69 10/15/2022204,800 shares $337,920.00 +17.7%1.7%2.2 $1.65 9/30/2022174,000 shares $281,880.00 +11.8%1.5%0.6 $1.62 9/15/2022155,600 shares $311,200.00 -20.3%1.3%0.5 $2.00 8/31/2022195,300 shares $515,592.00 +73.5%1.6%0.7 $2.64Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide ITRM Short Interest - Frequently Asked Questions What is Iterum Therapeutics' current short interest? Short interest is the volume of Iterum Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 1,200,000 shares of ITRM short. 7.50% of Iterum Therapeutics' shares are currently sold short. Learn More on Iterum Therapeutics' current short interest. What is a good short interest ratio for Iterum Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ITRM shares currently have a short interest ratio of 2.0. Learn More on Iterum Therapeutics's short interest ratio. What is a good short interest percentage for Iterum Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.50% of Iterum Therapeutics' floating shares are currently sold short. Is Iterum Therapeutics' short interest increasing or decreasing? Iterum Therapeutics saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 1,200,000 shares, a decline of 2.4% from the previous total of 1,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Iterum Therapeutics' float size? Iterum Therapeutics currently has issued a total of 16,430,000 shares. Some of Iterum Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Iterum Therapeutics currently has a public float of 16,010,000 shares. How does Iterum Therapeutics' short interest compare to its competitors? 7.50% of Iterum Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Iterum Therapeutics: Sensei Biotherapeutics, Inc. (0.50%), NRx Pharmaceuticals, Inc. (6.69%), Lipocine Inc. (5.41%), Bullfrog AI Holdings, Inc. (5.49%), Unity Biotechnology, Inc. (1.99%), Acasti Pharma Inc. (0.06%), Forte Biosciences, Inc. (0.09%), Biora Therapeutics, Inc. (4.33%), Lumos Pharma, Inc. (5.83%), CytoMed Therapeutics Limited (0.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Iterum Therapeutics stock? Short selling ITRM is an investing strategy that aims to generate trading profit from Iterum Therapeutics as its price is falling. ITRM shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Iterum Therapeutics? A short squeeze for Iterum Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ITRM, which in turn drives the price of the stock up even further. How often is Iterum Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ITRM, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Sensei Biotherapeutics Short Interest NRx Pharmaceuticals Short Interest Lipocine Short Interest Bullfrog AI Short Interest Unity Biotechnology Short Interest Acasti Pharma Short Interest Forte Biosciences Short Interest Biora Therapeutics Short Interest Lumos Pharma Short Interest CytoMed Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ITRM) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Report😱 This phenomenon is smashing regular market gainsMillPub#1 election stockPorter & CompanyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBiden out June 13; Kamala won’t replace him?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith